✦ LIBER ✦

The Unjustified Classification of Kidney Donors as Patients with CKD: Critique and Recommendations

✍ Scribed by Matas, A. J.; Ibrahim, H. N.

Book ID: 120498798
Publisher: American Society of Nephrology
Year: 2013
Tongue: English
Weight: 515 KB
Volume: 8
Category: Article
ISSN: 1555-9041
DOI: 10.2215/CJN.02110213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MMP-7 as a Potential Marker of Cardiovas

MMP-7 as a Potential Marker of Cardiovascular Complications in Patients with Chronic Kidney Disease (CKD)

✍ Kinga Musiał; Danuta Zwolińska 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

V1726 EXPANDING THE KIDNEY ORGAN DONOR P

V1726 EXPANDING THE KIDNEY ORGAN DONOR POOL AND REDUCING PATIENT WAIT LIST TIMES THROUGH UTILIZATION OF LIVING DONOR KIDNEYS WITH RENAL ANGIOMYOLIPOMAS

✍ Modlin, Charles; Flechner, Stuart; Aboumohamed, Ahmed; Mori, Ryan; Bass, Ragina; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

Clinical efficacy of the selective endot

Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)

✍ Dennis L. Andress; Blai Coll; Yili Pritchett; John Brennan; Mark Molitch; Donald 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Biological monitoring and tropical biodi

Biological monitoring and tropical biodiversity in marine environments: a critique with recommendations, and comments on the use of amphipods as bioindicators

✍ Thomas, J.D. 📂 Article 📅 1993 🏛 Taylor and Francis Group 🌐 English ⚖ 909 KB

Effects of atorvastatin on renal functio

Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: Rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial

✍ Kenji Ueshima,Masato Kasahara,Daisuke Koya… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 188 KB

THE CLINICAL SIGNIFICANCE OF MORPHOGENET

THE CLINICAL SIGNIFICANCE OF MORPHOGENETIC PROTEINS FGF-23 AND KLOTHO IN SERUM AS THE EARLY DIAGNOSTIC MARKERS OF CHRONIC KIDNEY DAMAGE AND TO ASSESS THE CARDIO-VASCULAR RISK IN PATIENTS WITH CKD

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 210 KB